Decentralized Clinical Trials
You need a modern DCT platform - powerful, flexible, innovative
Our industry is now, more than ever, ready to move to decentralized trials (DCT) and design hybrid protocols that support trial continuity and have a more patient-centric approach.
Through discussions with our clients, it’s clear that most sponsors have struggled to implement DCT and need an innovative, modern technology platform that enables more efficient and future-ready trial processes.
The unique architecture of encapsia brings the technology to the data and provides an agile, revolutionary way to support decentralized clinical trials, allowing:
- You to conduct a trial visit at a patient’s home, avoiding the need for patients to travel to site
- Easy to use eSource: encapsia Direct Data Capture (DDC) is an easy to use iOS app that can be accessed from anywhere in the world. Data is saved in real-time in the cloud and can be captured even when offline
- Smooth patient interaction: Sites can request drug dispensation, perform drug accountability, or randomize directly from the encapsia. As IRT data is automatically pushed to the platform in real time, patient contact time is smooth and quick. We also offer “hyper-integration” that adds even more speed to data delivery, reconciliation, and aggregation